Pharmacokinetics of estrogen and progesterone in chronic kidney disease

Advances in Chronic Kidney Disease

Volumn 11, Issue 4, 2004, Pages 357-360

  Anderson, Gail D ^a   Odegard, Peggy S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

estrogen; Hormone replacement therapy; kidney disease; pharmacokinetics; progesterone

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; ESTRONE; ESTRONE SULFATE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; PROGESTERONE;

CHRONIC KIDNEY DISEASE; DRUG EFFECT; DRUG ELIMINATION; DRUG METABOLISM; HORMONE SUBSTITUTION; HORSE; HUMAN; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 5444274630     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2004.07.001     Document Type: Article

References (27)

1. C. Longcope, W. Jaffee, G. Griffing Metabolic clearance rates of androgens and oestrogens in ageing women Maturitas 2 1980 283 290
2. A.R. Aedo, M. Sunden, B.M. Landgren Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women Maturitas 11 1989 159 168
3. D.R. Grow Metabolism of endogenous and exogenous reproductive hormones Obstet Gynecol Clin North Am 29 2002 425 436
4. K.C. Nichols, L. Schenkel, H. Benson 17 beta-estradiol for postmenopausal estrogen replacement therapy Obstet Gynecol Surv 39 1984 230 245
5. C. Longcope, K.I. Williams The metabolism of estrogens in normal women after pulse injections of 3H-estradiol and 3H-estrone J Clin Endocrinol Metab 38 1974 602 607
6. W. Kuhnz, C. Gansau, M. Mahler Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol Arzneimittelforschung 43 1993 966 973
7. M.B. O'Connell Pharmacokinetic and pharmacologic variation between different estrogen products J Clin Pharmacol 35 suppl 1995 18S 24S
8. M.R. Henzl, P.K. Loomba Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice J Reprod Med 48 2003 525 540
9. I. Setnikar, L.C. Rovati, A. Santoro Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch Arzneimittelforschung 49 1999 708 715
10. E.S. Ginsburg, X. Gao, B.F. Shea Half-life of estradiol in postmenopausal women Gynecol Obstet Invest 45 1998 45 48
11. B.R. Bhavnani Pharmacokinetics and pharmacodynamics of conjugated equine estrogens Chemistry and metabolism Proc Soc Exp Biol Med 217 1998 6 16
12. G.A. Greendale, H.L. Judd The menopause Health implications and clinical management J Am Geriatr Soc 41 1993 426 436
13. A.R. Aedo, B.M. Landgren, Z. Cekan Studies on the pattern of circulating steroids in the normal menstrual cycle. 2. Levels of 20alpha- dihydroprogesterone, 17-hydroxy-progesterone and 17-hydroxypregnenolone and the assessment of their value for ovulation prediction Acta Endocrinol (Copenh) 82 1976 600 616
14. H. Kuhl Pharmacokinetics of oestrogens and progestogens Maturitas 12 1990 171 197
15. B. de Lignieres Oral micronized progesterone Clin Ther 21 1999 41 60
16. J.W. McAuley, F.J. Kroboth, P.D. Kroboth Oral administration of micronized progesterone A review and more experience Pharmacotherapy 16 1996 453 457
17. A. Victor, E.D. Johansson Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally Contraception 14 1976 319 329
18. E.S. Ginsburg, W.F. Owen Jr, L.M. Greenberg Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease J Clin Endocrinol Metab 81 1996 4414 4417
19. E. van Kammen, J.H. Thijssen, G.H. Donker The excretion of metabolites of testosterone and of estradiol in male patients with chronic renal failure Steroids 26 1975 508 515
20. C. Stehman-Breen, G. Anderson, D. Gibson Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis Kidney Int 64 2003 290 294
21. J. Matuszkiewicz-Rowinska, K. Skorzewska, S. Radowicki The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis Nephrol Dial Transplant 14 1999 1238 1243
22. O. Ylikorkala, B. Cacciatore, I. Paakkari The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane Fertil Steril 69 1998 883 888
23. O.A. Dada, V. Laumas, B.M. Landgren Effect of graded oral doses of oestradiol on circulating hormonal levels Acta Endocrinol (Copenh) 88 1978 754 767
24. P.G. Whittaker, M.R. Morgan, P.D. Dean Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin') Lancet 1 1980 14 16
25. J. Studd, M. Savvas, N. Waston The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants Am J Obstet Gynecol 163 1990 1474 1479
26. A. Armston, P. Wood Hormone replacement therapy (oestradiol-only preparations) can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis? Ann Clin Biochem 39 2002 184 193
27. Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in post-menopausal women JAMA 273 1995 199 220